Taking place on 5 July: New concepts in COPD
Taking place on 5 July, this ERS Vision Live panel discussion will focus on new concepts in chronic obstructive pulmonary disease (COPD).
The expert panellists will discuss key areas, including:
Pharmacological management of COPD
Role of eosinophils as biomarkers in COPD
Pre-COPD, PRISm and early/young COPD
This event is free to access but registration is required.
Chairs: Alvar Agustí, Marta Drummond.
Speakers: Speakers: Prof. Dave Singh, Prof. Dr Claus Vogelmeier, Dr MeiLan Han
Date: 5 July, 2023 | 18:00–19:00 CEST
Fuente de la información en este link, donde también puedes apuntarte: https://www.ersnet.org/events/new-concepts-in-copd/#ProfMartaDrummond
Noticias relacionadas
Clinical impact of mucus plugs in bronchiectasis
Mucus plugs in bronchiectasis are associated with worse respiratory symptoms and chronic Pseudomonas aeruginosa infection in a study of 133 adults.
Using AI for COPD Diagnosis, Equity, Guideline Gaps: Alvar Agusti, MD, PhD
AI in COPD diagnosis can support case finding, spirometry interpretation and equity while GOLD 2026 highlights validation and guideline gaps.
Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trials
Astegolimab for COPD was evaluated in the ALIENTO and ARNASA trials to assess its efficacy and safety in patients with frequent exacerbations.
Más artículos
Últimos artículos
- 759397·Alberto Sandiumenge et Al.-Systemic Inflammation Differences in Brain-vs. Circulatory-Dead Donors: Impact on Lung Transplant Recipients
- 769385·GOLD 2023 Executive Summary: responses from the GOLD Scientific Committee
- 778987·Shyamali C Dharmage, et al. Lifetime spirometry patterns of obstruction and restriction, and their risk factors and outcomes: a prospective cohort study.
- 779175·José Luis Izquierdo, José Miguel Rodríguez, Carlos Almonacid, María Benavent, Ramón Arroyo-Espliguero, Alvar Agustí – Real-life burden of hospitalisations due to COPD exacerbations in Spain
- 779279·Alvar Agustí, Eleni Rapsomaniki, Richard Beasley, Rod Hughes, Hana Müllerová, Alberto Papi,Ian D. Pavord, Maarten van den Berge, Rosa Faner – Treatable traits in the NOVELTY study1. 2022
Recuerda que puedes acceder a varios enlaces a artículos dentro de la categoría EPOC en esta web. También puedes acceder otros enlaces en el Listado de Artículos de la Cátedra de Salud Respiratoria.
Imagen obtenida mediante capturas en el documento enlazado en la parte pública del artículo en (https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(22)00302-2/fulltext) : https://www.healthdata.org/sites/default/files/files/policy_report/2019/GBD_2017_Booklet.pdf